Activation of p38 MAPK induced peroxynitrite generation in LPS plus IFN-gamma-stimulated rat primary astrocytes via activation of iNOS and NADPH oxidase

Neurochem Int. 2008 May;52(6):1188-97. doi: 10.1016/j.neuint.2007.12.009. Epub 2007 Dec 27.

Abstract

We have shown that immunostimulated astrocytes produce excess nitric oxide (NO) and eventually peroxynitrite (ONOO(-)) that was closely associated with the glucose deprivation-potentiated death of astrocytes. The present study shows that activated p38 MAPK regulates ONOO(-) generation from lipopolysaccharide (LPS) plus interferon-gamma (IFN-gamma)-stimulated astrocytes. LPS+IFN-gamma-induced p38 MAPK activation and ONOO(-) generation were attenuated by SB203580 or SKF-86002, specific inhibitors of p38 MAPK. ONOO(-) generation was blocked by NADPH oxidase inhibitor, diphenyleneiodonium chloride, and nitric oxide synthase (NOS) inhibitor, N omega-nitro-L-arginine methyl ester, suggesting both enzymes are involved in ONOO(-) generation. Inhibition of p38 MAPK suppressed LPS+IFN-gamma-induced NO production through down-regulating inducible form of NOS expression. It also suppressed LPS+IFN-gamma-induced NADPH oxidase activation and eventually, the inducible form of superoxide production. Transfection with dominant negative vector of p38 alpha reduced LPS+IFN-gamma-induced ONOO(-) generation through blocking both iNOS-derived NO production and NADPH oxidase-derived O2(-) production. Our results suggest that activated p38 MAPK may serve as a potential signaling molecule in ONOO(-) generation through dual regulatory mechanisms, involving iNOS induction and NADPH oxidase activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Astrocytes / drug effects
  • Astrocytes / enzymology*
  • Astrocytes / immunology
  • Cells, Cultured
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Encephalitis / enzymology*
  • Encephalitis / immunology
  • Encephalitis / physiopathology
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • Enzyme Inhibitors / pharmacology
  • Interferon-gamma / immunology
  • Interferon-gamma / pharmacology
  • Lipopolysaccharides / pharmacology
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • NADPH Oxidases / metabolism*
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase Type II / metabolism*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Peroxynitrous Acid / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Peroxynitrous Acid
  • Nitric Oxide
  • Interferon-gamma
  • Nitric Oxide Synthase Type II
  • NADPH Oxidases
  • p38 Mitogen-Activated Protein Kinases